ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares rose 0.8% during mid-day trading on Monday . The stock traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares were traded during trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Trading Up 0.8 %
The company has a market cap of C$162.08 million and a price-to-earnings ratio of -7.30. The firm has a fifty day moving average price of C$6.50 and a 200 day moving average price of C$6.50. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- Consumer Staples Stocks, Explained
- Energy Transfer: Powering Data With Dividends and Diversification
- Investing in Travel Stocks Benefits
- Qualcomm Stock Is Coiling for a Breakout
- Comparing and Trading High PE Ratio Stocks
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
